CELL-MEDIATED IMMUNITY TO ORBITAL TISSUE ANTIGENS IN THYROID-ASSOCIATED OPHTHALMOPATHY DETERMINED USING THE LEUKOCYTE PROCOAGULANT ACTIVITY ASSAY

References

• Wall J R. Autoimmunity and Graves' ophthalmopathy. The Eye and Orbit Thyroid Disease, C Gorman, R Waller, J Dyer. Raven Press, New York 1984; 103–114
   Google Scholar
• Wall J R, Salvi M, Bernard N. Eye disease and autoimmune thyroid disorders: mechanisms for the association. Pathogenesis and Management of Graves' Ophthalmopathy. Contemporary issues in Endocrinol, and Metab, J R Wall, J How. Blackwell Scientific Pubs. Inc. 1989; vol 1: 63–77
   Google Scholar
• Salvi M, Fukazawa H, Bernard N, Hiromatsu Y, How J, Wall J R. Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders. Endocr Rev 1988; 9: 450–466
   PubMed Web of Science ®Google Scholar
• Wall J R, Salvi M, Bernard N F, Haegert D. Thyroid‐associated ophthalmopathy–a model for the association of organ‐specific autoimmune disorders. Immunology Today 1991; 12: 150–153
   PubMedGoogle Scholar
• Kodama K, Sikorska H, Bandy‐Dafoe P, Bayly R, Wall J R. Demonstration of a circulating autoantibody against a soluble eye muscle antigen in Graves' ophthalmopathy. Lancet 1982; ii: 1353–1356
   Google Scholar
• Salvi M, Bernard N, Miller A, Zhang Z ‐G, Gardini E, Wall J R. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid‐associated ophthalmopathy. Thyroid 1991; 1: 207–213
   PubMedGoogle Scholar
• Hiromatsu Y, Fukazawa H, How J, Wall J R. Antibody‐dependent cell‐mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy–roles of Class II MHC antigen expression and interferon‐ y action on effector and target cells. Clin Exp Immunol 1987; 70: 593–604
   PubMed Web of Science ®Google Scholar
• Salvi M, Miller A, Wall J R. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by antoantibodies in serum of patients with thyroid‐associated ophthalmopathy. FEBS Lett 1988; 232: 135–139
   PubMed Web of Science ®Google Scholar
• Mahieu P, Winand R. Demonstration of delayed hypersensitivity to retrobulbar and thyroid tissues in human exophthalmos. J Clin Endocrinol Metab 1972; 34: 1090–1092
   PubMed Web of Science ®Google Scholar
• Munro R E, Lamki L, Row V V, Volpe R. Cell‐mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test. J Clin Endocrinol Metab 1973; 37: 286–292
   PubMed Web of Science ®Google Scholar
• Wall J R, Trervin A, Joyner D M. Peripheral blood lymphocyte transformation in response to human thyroid fractions in patients with Graves' hyperthyroidism and ophthalmopathy. Acta Endocrinologica 1980; 93: 419–423
   Google Scholar
• Wall J R, Walters B A, Grant C. Leukocyte inhibition in response to human orbital and lacrimal extractions in patients with Graves' ophthalmopathy. J Endocrinol Invest 1979; 2: 375–378
   PubMed Web of Science ®Google Scholar
• Weetman A P, Cohen S, Gatter K C, Fells P, Shine B. Immuno‐histochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989; 75: 222–227
   PubMed Web of Science ®Google Scholar
• Levi G, Edgington T. Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med 1980; 151: 1232–1244
   Google Scholar
• Iiataka M, Bernstein J, Gerstein H C, Iwatani Y, Row V V, Volpe R. Sensitization of T lymphocytes to thyroid antigen in autoimmune thyroid disease as demonstrated by the monocyte procoagulant activity test. J Endocrinol Invest 1986; 9: 471–478
   Google Scholar
• Greczy C L, Meyer P A. Leukocyte procoagulant activity in man: an in vitro correlate of delayed‐type hypersensitivity. J Immunol 1982; 128: 331–336
   Google Scholar
• How J, Hiromatsu Y, Wang P, Salvi M, Wall J R. Cellular mechanisms for autoimmune damage in thyroid‐associated ophthalmopathy. Thyroid Autoimmunity, A Pinchera, S H Ingbar, J M McKenzie. Plenum, New York 1987; 125–133
   Google Scholar
• Laemmli U K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227: 680–734
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, How J, Fukazawa H, Guinard F, Salvi M, How J, Wall J R. A thyroid cytotoxic antibody that cross‐reacts with an eye muscle cell surface antigen may be the cause of thyroid‐associated ophthalmopathy. J Clin Endocrinol Metab 1988; 67: 565–570
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Cadarso L, Salvi M, Wall J R. Significance of cytotoxic eye muscle antibodies in patients with thyroid‐associated ophthalmopathy. Autoimmunity 1990; 5: 205–213
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Wang P W, Wosu L, How J, Wall J R. Mechanisms of immune damage in Graves' ophthalmopathy. Hor Res 1987; 26: 198–207
   PubMedGoogle Scholar
• Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol (Copenh) 1989; 120: 473–478
   PubMedGoogle Scholar
• Wall J R, Dong Q, Salvi M, Bernard N, Miller A, Vassart G, Ludgate M. Antibodies against a rcombinant 97 amino acid fragment of a 64 kDa protein in patients with thyroid‐associated opthalmopathy. Proc. 73rd Annual Meeting of the Endocrine Society. June, 19–221991. Washington, D.C., (Abstract #851)
   Google Scholar
• Feldmann M, Londei M. Analysis of endocrine autoimmunity by cloning human T lymphocytes from target tissues. Endocrine and Other Organ‐Oriented Autoimmune Disorders. Ballière's Clin Immunology and Allergy, D Doniach, G F Bottazzo. Bailliere Tindall, London 1987; 1: 101–108
   Google Scholar
• Dong Q, Ludgate M, Vassart G. Cloning and sequencing of a 64 kDa autoantigen expressed in the thyroid and extra‐ocular muscle. J Clin Endocrinol Metab 1991; 72: 1375–1381
   PubMed Web of Science ®Google Scholar